home / stock / anpcf / anpcf short
Short Information | Angle Plc Ord (OTCMKTS:ANPCF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 27,359 |
Total Actual Volume | 31,859 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 9 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,368 |
Average Short Percentage | 45.45% |
Is there a ANPCF Short Squeeze or Breakout about to happen?
See the ANPCF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $0.1964 | $0.1964 | $0.1964 | $0.1964 | 600 | 600 | 100% |
01-23-2024 | $0.234 | $0.234 | $0.234 | $0.234 | 3,000 | 3,000 | 100% |
01-04-2024 | $0.35 | $0.35 | $0.35 | $0.35 | 2,500 | 2,500 | 100% |
11-09-2023 | $0.148 | $0.148 | $0.148 | $0.148 | 5,000 | 5,000 | 100% |
08-15-2023 | $0.15 | $0.16678 | $0.16678 | $0.15 | 4,950 | 450 | 9.09% |
06-24-2022 | $1.35 | $1.35 | $1.35 | $1.35 | 5,000 | 5,000 | 100% |
03-16-2022 | $1.12 | $1.12 | $1.12 | $1.12 | 5,000 | 5,000 | 100% |
01-23-2020 | $N/A | $0.91 | $N/A | $N/A | 4,600 | 4,600 | 100% |
01-09-2020 | $0.91 | $0.91 | $0.91 | $0.91 | 209 | 209 | 100% |
10-31-2019 | $0.92 | $0.92 | $0.92 | $0.92 | 1,000 | 1,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
GUILDFORD, SURREY / ACCESSWIRE / July 12, 2024 / TR-1: Standard form for notification of major holdings This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the Un...
GUILDFORD, SURREY / ACCESSWIRE / July 11, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed. For further information: Notes for editors About ANG...
GUILDFORD, SURREY / ACCESSWIRE / June 18, 2024 / ANGLE plc ("the Company") (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, announces that the audited Annual Report a...